Medindia

X

Med-Emerg International Inc. reports improved income from operations

Friday, August 15, 2008 General News J E 4
Advertisement
TORONTO, Aug. 14 /PRNewswire-FirstCall/ - Med-Emerg International Inc. (OTCBB - MDER), announced today that revenue from continuing operations, for the three months ended June 30, 2008 were $6.1 million compared to $5.3 million for the same period in 2007 (all amounts are $US unless otherwise stated). For the three month period, income from continuing operations improved to $164K from $15K in 2007. The improvement was driven by improved performance with all operating divisions.

The Company reported income attributable to common shareholders in the quarter of $281K ($0.005 per share) in 2008, compared to a loss of ($236K) ($0.004 per share) in 2007.

The Company's financial statement information is summarized below:



MedEmerg specializes in the coordination and delivery of health care services in Canada and overseas. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.



All statements included in this press release that are not statements of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "plan", "expect", "believe", "intend", "anticipate", "forecast", "target", "estimate" and similar expressions identify forward-looking statements. Forward-looking statements are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These risks and uncertainties are outlined in the Company's Annual Report on Form 10-K for 2007, and such other documents as are filed with the Securities and Exchange Commission from time to time. The Company does not undertake to review or update these forward-looking statements. The Company qualifies all of the information contained in this press release, and particularly its forward-looking statements, by these cautionary statements.

(US$000's except share information) Three Months Ended Six Months Ended June 30 June 30 -------------------------- -------------------------- -------------------------- -------------------------- 2008 2007 2008 2007 Revenue 6,131 5,252 11,596 10,074 EBITDA 271 108 450 (41) Income (loss) from continuing operations 164 15 245 (203) Income (loss) from discontinued operations 117 (251) 30 (363) Net income (loss) attributable to common shareholders 281 (236) 275 (566) Net income (loss) per common share (basic) Continuing operations $ 0.003 $ 0.000 $ 0.004 $ (0.003) Discontinued operations $ 0.002 $ (0.004) $ 0.001 $ (0.006) Weighted average shares outstanding, basic 58,277,696 58,277,696 58,277,696 58,277,696 Income (loss) per common share, diluted Continuing operations $ 0.002 $ 0.000 $ 0.004 $ (0.003) Discontinued operations $ 0.002 $ (0.004) $ 0.000 $ (0.006) Weighted average common shares and share equivalents, diluted 67,027,696 58,277,696 67,027,696 58,277,696 -------------------------- -------------------------- (US$000's)
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pharmasset Reports Financial Results for Quarter E...
S
Pressure BioSciences, Inc. Reports Second Quarter ...